The onset of the COVID-19 pandemic witnessed a surge in acute cholecystitis (AC) cases, with potential correlations to SARS-CoV-2 infection. The ChoCO-W global prospective study reported a higher incidence of gangrenous cholecystitis and adverse outcomes in COVID-19 patients compared with non-COVID patients. The ChoCO-W2 study aims to investigate factors associated with mortality among patients admitted with AC during the COVID-19 pandemic.
Is COVID-19 infection a risk factor for death in patients presenting acute cholecystitis? The ChoCO-W global study post-hoc analysis.
Belinda De Simone
2024-01-01
Abstract
The onset of the COVID-19 pandemic witnessed a surge in acute cholecystitis (AC) cases, with potential correlations to SARS-CoV-2 infection. The ChoCO-W global prospective study reported a higher incidence of gangrenous cholecystitis and adverse outcomes in COVID-19 patients compared with non-COVID patients. The ChoCO-W2 study aims to investigate factors associated with mortality among patients admitted with AC during the COVID-19 pandemic.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
